MetalloBio's mission is fundamentally to change the nature of antibiotics and the treatment of infections.
In November this year, MetalloBio’s CEO Dr. Michael Murray, together with Lead Scientist – Materials, Dr. Matt Culbert, and Lead Scientist – Chemistry, Dr. Simon Fairbanks, will be attending Medica 2025 in Düsseldorf. Across the four days, the team will be engaging with medtech companies with an interest in antibacterial coatings and additives.